Canary At The Pharma Counter----Drastically Overbuilt Walgreens Rated A Rare "Sell" By Goldman

Goldman analyst Robert Jones said he doesn't think these partnerships, even if expanded, will help enough to offset declines in Walgreens' core retail pharmacy business, according to a research note sent to clients Friday. Jones downgraded Walgreens to "sell" from "hold" Friday.

 

 

 

https://www.cnbc.com/2018/12/14/goldman-doubts-walgreens-strategy-is-enough-to-offset-challenges.html?__source=twitter%7Cmain

David Stockman's Contra Corner is the only place where mainstream delusions and cant about the Warfare State, the Bailout State, Bubble Finance and Beltway Banditry are ripped, refuted and rebuked. Subscribe now to receive David Stockman’s latest posts by email each day as well as his model portfolio, Lee Adler’s Daily Data Dive and David’s personally curated insights and analysis from leading contrarian thinkers.